Cedars-Sinai Health Sciences University investigators have developed and successfully tested a new treatment for pregnant women with severe early preeclampsia, a leading cause of premature birth as well as maternal and fetal death. The early-stage international study, published in the journal Nature Medicine, focused on removing a harmful protein from a mother’s blood.
This article was originally published on MedicalXpress.com

